Hematocure
@hematocure.bsky.social
Dedicated to collaborating with healthcare professionals, biotech and pharma to bring cutting-edge therapies and diagnostics to patients
In 2025, an estimated 1.3 million worldwide will be diagnosed. Early diagnosis can transform outcomes, offering patients the promise of longer, healthier lives. Stay informed, take action, and be a voice for those affected. #BloodCancerAwareness
www.hematocure.com/post/septemb...
www.hematocure.com/post/septemb...
September is Blood Cancer Awareness Month
September 1, 2025. September is Blood Cancer Awareness Month. In 2025, an estimated 1.3 million people worldwide will be newly diagnosed with blood cancer. At Hematocure, we are dedicated to working a...
www.hematocure.com
September 2, 2025 at 2:06 AM
In 2025, an estimated 1.3 million worldwide will be diagnosed. Early diagnosis can transform outcomes, offering patients the promise of longer, healthier lives. Stay informed, take action, and be a voice for those affected. #BloodCancerAwareness
www.hematocure.com/post/septemb...
www.hematocure.com/post/septemb...
The full abstracts selected for #IMS25 have just been released!
conferenceabstracts.com/uploads/docume…
We are eagerly anticipating the great science to be showcased in Toronto in three weeks. Hematocure will attend, provide updates, and looks forward to reconnecting with colleagues.#mmsmsm
conferenceabstracts.com/uploads/docume…
We are eagerly anticipating the great science to be showcased in Toronto in three weeks. Hematocure will attend, provide updates, and looks forward to reconnecting with colleagues.#mmsmsm
August 28, 2025 at 10:51 PM
The full abstracts selected for #IMS25 have just been released!
conferenceabstracts.com/uploads/docume…
We are eagerly anticipating the great science to be showcased in Toronto in three weeks. Hematocure will attend, provide updates, and looks forward to reconnecting with colleagues.#mmsmsm
conferenceabstracts.com/uploads/docume…
We are eagerly anticipating the great science to be showcased in Toronto in three weeks. Hematocure will attend, provide updates, and looks forward to reconnecting with colleagues.#mmsmsm
Reposted by Hematocure
DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%
www.statnews.com/2025/05/09/t...
www.statnews.com/2025/05/09/t...
From pandemic preparedness to precious frozen spit, NIH contract terminations cut deep
DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%
www.statnews.com
May 9, 2025 at 1:48 PM
DOGE lists just over 400 NIH contracts it says have been cancelled under its directive to reduce contract spending by 35%
www.statnews.com/2025/05/09/t...
www.statnews.com/2025/05/09/t...
Reposted by Hematocure
Now online in Cancer Discovery: An Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer - by Wenyan Xie, Xin Yu, Qingxin Yang, Nengwen Ke, Ping Wang, Yun-Hua Liu, Bi-Sen Ding, Qiang Wei, Hong Jiang, and colleagues doi.org/10.1158/2159...
May 8, 2025 at 3:25 PM
Now online in Cancer Discovery: An Immunomechanical Checkpoint PYK2 Governs Monocyte-to-Macrophage Differentiation in Pancreatic Cancer - by Wenyan Xie, Xin Yu, Qingxin Yang, Nengwen Ke, Ping Wang, Yun-Hua Liu, Bi-Sen Ding, Qiang Wei, Hong Jiang, and colleagues doi.org/10.1158/2159...
Reposted by Hematocure
#ICYMI: Scientists and former agency heads spoke about the crisis in public funding for cancer research at the AACR Annual Meeting 2025. Learn more in Cancer Today magazine: www.cancertodaymag.org/cancer-talk/... #AACR25
Federal Support for Cancer Research Takes the Stage at AACR Annual Meeting | Cancer Today
Scientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
www.cancertodaymag.org
May 4, 2025 at 3:57 PM
#ICYMI: Scientists and former agency heads spoke about the crisis in public funding for cancer research at the AACR Annual Meeting 2025. Learn more in Cancer Today magazine: www.cancertodaymag.org/cancer-talk/... #AACR25
Reposted by Hematocure
Myeloid neoplasms may arise after prior cytotoxic chemotherapy and/or large-field radiation therapy, commonly associated with TP53 mutations, and complex karyotype with frequent 5q/7q/17p loss. buff.ly/CnosfH9 #hemesky #bloodwork
May 9, 2025 at 3:05 PM
Myeloid neoplasms may arise after prior cytotoxic chemotherapy and/or large-field radiation therapy, commonly associated with TP53 mutations, and complex karyotype with frequent 5q/7q/17p loss. buff.ly/CnosfH9 #hemesky #bloodwork
FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
www.fda.gov/news-events/...
www.fda.gov/news-events/...
FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
FDA announced an aggressive timeline to scale AI across all centers by June 30.
www.fda.gov
May 9, 2025 at 3:05 PM
FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline
www.fda.gov/news-events/...
www.fda.gov/news-events/...
Delays at FDA continue as Agency misses approval decision target date for GSK's Nucala in COPD
www.fiercepharma.com/pharma/fda-m...
www.fiercepharma.com/pharma/fda-m...
FDA misses another approval decision target date, this time for GSK's Nucala in COPD
In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. | GSK had expected to secure an FDA no...
www.fiercepharma.com
May 9, 2025 at 3:02 PM
Delays at FDA continue as Agency misses approval decision target date for GSK's Nucala in COPD
www.fiercepharma.com/pharma/fda-m...
www.fiercepharma.com/pharma/fda-m...
Reposted by Hematocure
Really happy to share this amazing story from my talented colleague Felipe Galvez-Cancino and many others. Really interesting work about the nature of anti-tumour immunity in the brain and how it can be modulated, in mice and humans!
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Regulatory T cell depletion promotes myeloid cell activation and glioblastoma response to anti-PD1 and tumor-targeting antibodies
Glioblastoma is invariably lethal and responds poorly to immune checkpoint blockade. Here, we examined the impact of regulatory T (Treg) cell depletio…
www.sciencedirect.com
April 24, 2025 at 7:31 PM
Really happy to share this amazing story from my talented colleague Felipe Galvez-Cancino and many others. Really interesting work about the nature of anti-tumour immunity in the brain and how it can be modulated, in mice and humans!
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Hematocure
The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.
In a reversal, the Trump administration restores funding for women's health study
The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.
www.npr.org
April 25, 2025 at 12:36 AM
The unexpected elimination of funding for the decades-long research project focused on women's health shocked scientists. They were heartened by the quick restoration of support.
Reposted by Hematocure
Cells are swapping their mitochondria. What does this mean for our health?
Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 🧪🦠💊
www.nature.com/articles/d41...
Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 🧪🦠💊
www.nature.com/articles/d41...
April 10, 2025 at 8:16 PM
Cells are swapping their mitochondria. What does this mean for our health?
Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 🧪🦠💊
www.nature.com/articles/d41...
Researchers are studying why the energy factories are moving between cells and whether the process can be harnessed to treat cancer and other diseases. 🧪🦠💊
www.nature.com/articles/d41...
Why an overreliance on AI-driven modeling could be bad for science
The authors of a Comment article in Nature write that hopes are high that AI can accelerate scientific discovery but warn that the rush to adopt AI has consequences. “Establishing clear scientific guidelines on how to use these tools and techniques is urgent.” 🧪
Why an overreliance on AI-driven modelling is bad for science
Without clear protocols to catch errors, artificial intelligence’s growing role in science could do more harm than good.
go.nature.com
April 8, 2025 at 4:58 PM
Why an overreliance on AI-driven modeling could be bad for science
Reposted by Hematocure
Editorial @jci-insight.bsky.social
Science: our past, our present, and always our future
insight.jci.org/articles/vie...
Science: our past, our present, and always our future
insight.jci.org/articles/vie...
April 8, 2025 at 4:47 PM
Editorial @jci-insight.bsky.social
Science: our past, our present, and always our future
insight.jci.org/articles/vie...
Science: our past, our present, and always our future
insight.jci.org/articles/vie...
Reposted by Hematocure
Perspective @jci-insight.bsky.social
Paving the physician-scientist career path: from grassroots gathering to national forum
insight.jci.org/articles/vie...
Paving the physician-scientist career path: from grassroots gathering to national forum
insight.jci.org/articles/vie...
April 8, 2025 at 4:51 PM
Perspective @jci-insight.bsky.social
Paving the physician-scientist career path: from grassroots gathering to national forum
insight.jci.org/articles/vie...
Paving the physician-scientist career path: from grassroots gathering to national forum
insight.jci.org/articles/vie...
Reposted by Hematocure
Research shows ferritin <30 µg/L indicates iron deficiency, but some labs still use a cutoff as low as 8 µg/L. This means thousands of people are told their iron levels are “normal” when they are deficient. Better screening is needed. Read the full article: https://bit.ly/4c901LU
April 8, 2025 at 2:00 PM
Research shows ferritin <30 µg/L indicates iron deficiency, but some labs still use a cutoff as low as 8 µg/L. This means thousands of people are told their iron levels are “normal” when they are deficient. Better screening is needed. Read the full article: https://bit.ly/4c901LU
Reposted by Hematocure
🚨🎉🎊Congratulations to Blood Immunology & Cellular Therapy first published paper, Talquetamab in Heavily Pretreated Multiple Myeloma Patients, Including BCMA-Refractory. buff.ly/Y5Dh6hP
April 8, 2025 at 3:01 PM
🚨🎉🎊Congratulations to Blood Immunology & Cellular Therapy first published paper, Talquetamab in Heavily Pretreated Multiple Myeloma Patients, Including BCMA-Refractory. buff.ly/Y5Dh6hP
